Showing results (11-20 of 20) with videos related to
Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Clinical Neuropharmacology|June 11, 2004
Neurokinin B, neurotensin, and cannabinoid receptor antagonists and Parkinson diseaseV Mesnage, J L Houeto, A M Bonnet, et al.Neurology|April 10, 2002
Parkinson's disease and sleepiness: an integral part of PDI Arnulf, E Konofal, M Merino-Andreu, et al.Journal of Neurology, Neurosurgery, and Psychiatry|May 23, 2002
Behavioural disorders, Parkinson's disease and subthalamic stimulationJ L Houeto, V Mesnage, L Mallet, et al.Brain : a Journal of Neurology|March 2, 2002
Clinical predictive factors of subthalamic stimulation in Parkinson's diseaseM L Welter, J L Houeto, S Tezenas du Montcel, et al.Revue Neurologique|March 22, 2008
[Multiple sclerosis: immunomodulators, education, and self-injection]N Moinot, O Anne, J-L Devoize, et al.Journal of Neurology, Neurosurgery, and Psychiatry|June 21, 2005
Tourette's syndrome and deep brain stimulationJ L Houeto, C Karachi, L Mallet, et al.Neurology|May 11, 2005
Parkinson disease, brain volumes, and subthalamic nucleus stimulationF Bonneville, M L Welter, C Elie, et al.Journal of Neurology, Neurosurgery, and Psychiatry|November 18, 2005
Stimulation of the subthalamic nucleus in Parkinson's disease: a 5 year follow upW M M Schüpbach, N Chastan, M L Welter, et al.American Journal of Human Genetics|August 12, 1999
Early-onset autosomal dominant Alzheimer disease: prevalence, genetic heterogeneity, and mutation spectrumD Campion, C Dumanchin, D Hannequin, et al.Journal of Neurology, Neurosurgery, and Psychiatry|March 18, 2006
Clinical and economic results of bilateral subthalamic nucleus stimulation in Parkinson's diseaseV Fraix, J-L Houeto, C Lagrange, et al.Pageof 2